Clinical Trial Update: Immunogenicity of One Versus Two Doses of Killed Oral Cholera Vaccine [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the immunogenicity of one versus two doses of a killed oral cholera vaccine; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholera
• Diarrhea
• Vibrio Infections

Drugs mentioned

• Killed oral cholera vaccine

Snippet

Sponsor: International Vaccine Institute | Conditions: Cholera, Diarrhea | Phase 2 | Status: COMPLETED